We are live on ! Find out more
PODD icon

Insulet

563 hedge funds and large institutions have $12B invested in Insulet in 2024 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 225 increasing their positions, 183 reducing their positions, and 103 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 225 | Existing positions reduced: 183

0.93% less ownership

Funds ownership: 101.08%100.15% (-0.93%)

5% less funds holding

Funds holding: 591563 (-28)

20% less first-time investments, than exits

New positions opened: 82 | Existing positions closed: 103

22% less capital invested

Capital invested by funds: $15.3B → $12B (-$3.3B)

50% less funds holding in top 10

Funds holding in top 10: 63 (-3)

66% less call options, than puts

Call options by funds: $70.3M | Put options by funds: $209M

Holders
563
Holders Change
-28
Holders Change %
-4.74%
% of All Funds
8.09%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
82
Increased
225
Reduced
183
Closed
103
Calls
$70.3M
Puts
$209M
Net Calls
-$138M
Net Calls Change
-$49.8M

PODD Hedge Fund Activity: Q1 2024 in Review

563 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2024, worth a combined $12B — down 22% from $15.3B a quarter earlier.

Sellers outnumbered buyers: 103 funds closed out of PODD and 82 opened new positions — a net loss of 21 holders — while 183 trimmed existing stakes and 225 added.

The largest buyer was Ameriprise, adding an estimated $128M. The largest seller was Capital World Investors, cutting an estimated $381M.

  • 563 institutional investors held Insulet (PODD) as of Q1 2024, down from 591 in Q4 2023.
  • Funds reported $12B of Insulet stock for Q1 2024, down 22% quarter-over-quarter.
  • 82 funds opened new Insulet positions in Q1 2024 and 103 closed out, a net change of -21 holders.
  • The largest Insulet buyer in Q1 2024 was Ameriprise, an estimated $128M added.
  • The largest Insulet seller in Q1 2024 was Capital World Investors, an estimated $381M sold.

Based on aggregated 13F filings for Q1 2024.